This study is accepting new patients by invitation only

Health eHeart BioBank

a study on Heart Disease Vascular Disease Cardiovascular Disease

Summary

Eligibility
for people ages 18 years and up (full criteria)
Healthy Volunteers
healthy people welcome
Location
at San Francisco, California
Dates
study started
completion around
Principal Investigator
by Jeffrey E Olgin, MDGregory Marcus, MDVasanth Vedantham, MDConnor G O'Brien, MDJames P Pirruccello, MD
Headshot of Jeffrey E Olgin
Jeffrey E Olgin
Headshot of Gregory Marcus
Gregory Marcus
Headshot of Vasanth Vedantham
Vasanth Vedantham
Headshot of James P Pirruccello
James P Pirruccello

Description

Summary

The purpose of the Health eHeart BioBank is to collect and store specimen (e.g. blood, DNA, tissue) for future studies at the University of California, San Francisco (UCSF) that will help determine changes and identify molecular and genetic markers in the human body that might help increase our knowledge of heart disease and guide development of new diagnostic tools and treatments that may help rapidly detect heart disease and prevent and/or treat heart disease.

Keywords

Heart Diseases, Cardiac Diseases, Vascular Diseases, Cardiovascular Diseases, Heart Disease, Cardiovascular Disease, Cardiology, Blood Draw, Tissue Collection, DNA Collection, Medical Chart Review

Eligibility

You can join if…

Open to people ages 18 years and up

  • Age ≥ 18 years or older.

And at least one of the following:

  • Established patient seen at UCSF and/or is a current participant in a clinical study that utilizes the HeH BioBank for biospecimen collection.
  • Family member of a patient with cardiovascular disease.
  • Patient with no cardiovascular disease.

You CAN'T join if...

  • Unwilling to consent to biospecimen collection through the HeH BioBank.

Location

  • UCSF
    San Francisco California 94158 United States

Lead Scientists at UCSF

  • Jeffrey E Olgin, MD
    Dr. Olgin is a Cardiologist and a Cardiac Electrophysiologist. His main clinical interests include conduction disorders, arrhythmias, catheter ablation, implantable devices—pacemakers and defibrillators, atrial fibrillation, atrial flutter, ventricular tachycardia, sudden death and supraventricular tachycardia.
  • Gregory Marcus, MD
    Dr. Gregory Marcus is a specialist in the treatment of arrhythmias, including mapping and catheter ablation for atrial fibrillation, supraventricular tachycardias and ventricular arrhythmias. He is also an expert in pacemaker, biventricular device and defibrillator implantation. RESEARCH Dr. Marcus is Associate Chief of Cardiology for Research at UCSF Health. He is also an Ass…
  • Vasanth Vedantham, MD
    Dr. Vedantham is cardiologist and clinical cardiac electrophysiologist, specializing in treatment of heart rhythm disorders using catheter ablation, pacemaker and defibrillator implantation, and antiarrhythmic medications.
  • Connor G O'Brien, MD
  • James P Pirruccello, MD
    Interested in the prevention of cardiac and aortic diseases, and in the use of genetic information to inform cardiovascular care. Dr. Pirruccello studies cardiovascular and aortic diseases using machine learning and genetics. He uses machine learning to quantify the heart, and to create new types of measurements that can help us to better understand health and disease.

Details

Status
accepting new patients by invitation only
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT06976502
Study Type
Observational [Patient Registry]
Participants
Expecting 500000 study participants
Last Updated